Estudios Realizados
Advantages
The 8 existing cell groups in SVF are obtained, with high number of live ADSCs and no apoptosis.
Enzymatic reagent developed by Lyposmol with the highest quality, effectiveness and optimization in obtaining SVF.
Fastest system on the market (
CE Certificate for the grouping of medical devices
Enzymatic reagent packaged in clean room N5 White and fulfilling Ph. Eur.
Performed in the same surgical act and without substantial manipulation.
Standard Work Procedure included in the kit.
Operating room ambulatory minor surgery.
Immediate Therapy, Same Surgical Act.
The best cost / effectiveness of the market.
Total treatment time >< 90min.
Products developed to the highest quality standards in the market.
Closed system with no risk of contamination.
Biosafety studies, own and by external laboratories, guarantee the Lyposmol ADSC System® process.
Autologous implant, without risks of reactions and intolerances